Women living with HIV still lack highly effective contraception: results from the ANRS VESPA2 study, France, 2011

被引:12
|
作者
Maraux, B. [1 ]
Hamelin, C. [1 ,2 ]
Bajos, N. [1 ,3 ,4 ]
Dray-Spira, R. [5 ,6 ]
Spire, B. [7 ,8 ,9 ]
Lert, F. [1 ,2 ]
机构
[1] Ctr Rech Epidemiol & Sante Populat, INSERM, U1018, Villejuif, France
[2] Univ Versailles St Quentin Yvelines, Villejuif, France
[3] INED, Paris, France
[4] Univ Paris 11, Le Kremlin Bicetre, France
[5] Inst Pierre Louis Epidemiol & Sante Publ, Equipe Rech Epidemiol Sociale, INSERM, UMRS 1136, Paris, France
[6] Univ Paris 06, Sorbonne Univ, Inst Pierre Louis Epidemiol & Sante Publ, Equipe Rech Epidemiol Sociale,UMR S 1136, Paris, France
[7] INSERM UMRS 912 SESSTIM, Marseille, France
[8] Aix Marseille Univ, IRD, UMRS 912, Marseille, France
[9] ORS PACA, Observ Reg Sante Provence Alpes Cote Dazur, Marseille, France
关键词
HIV; Women; Contraception; Dual method protection; France; REPRODUCTIVE HEALTH; INFECTED WOMEN; CONVERSATIONS; GUIDELINES; PREGNANCY; PROVIDERS;
D O I
10.1016/j.contraception.2015.04.010
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objectives: Advances in antiretroviral treatment (ART) have led to improvements in reproductive health for women living with HIV. This paper aims to investigate the pattern of contraceptive use among women living with HIV in France. Study design: Data were drawn from the ANRS VESPA2 study, which included a representative sample of HIV-positive people. Contraception methods were documented, including condoms, highly effective contraception methods (HEC) and traditional methods. We measured the frequency of not using any modern contraception (neither condoms nor HEC) and of HEC use and studied their correlates (i.e., geographic origin, age, parity, partnership status, education level, material deprivation, employment status, health insurance, visits to a gynecologist, being on ART, cardiovascular risk) among women at risk of an unintended pregnancy. Results: Of the 662 women of reproductive age, 327 were in need of contraception. Overall, 20.5% used HEC, 58.8% used condoms and 20.7% used traditional or no methods, with no difference according to geographic origin [sub-Saharan African (SSA) women vs. French and other migrant women]. Among SSA women, being <30 years old [odds ratio (OR) 16.39, 95% confidence interval (95%CI) 2.77-97.01], having had at least one child (OR 3.75, 95%CI 1.75-8.04) and being employed (OR 2.36, 95%CI 0.99-5.61) were associated with HEC use; among French and other migrant women, HEC use was associated with being in a stable partnership (OR 4.5, 95%CI 1.2-17.2) and material deprivation (OR 3.3 95%CI 1.4-9.8). Gynecologist visits, health insurance status and cardiovascular risk were not associated with HEC use. Conclusions: Condoms remained the predominant contraceptive method despite the absence of restrictions on hormonal contraception and intrauterine device use for HIV-positive women. The recent recommendations about dual method protection should be actively promoted, targeting HIV-positive women, HIV specialists and gynecologists to overcome the barriers to effective contraception. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:160 / 169
页数:10
相关论文
共 50 条
  • [41] Performance of visual inspection, partial genotyping, and their combination for the triage of women living with HIV who are screen positive for human papillomavirus: Results from the AIMA-CC ANRS 12375 multicentric screening study
    Debeaudrap, Pierre
    Kabore, Firmin Nongodo
    Setha, Limsreng
    Tegbe, Joseph
    Doukoure, Brahima
    Sotheara, Moeung
    Segeral, Olivier
    Aun, Korn
    Messou, Eugene
    Bitolog, Pauline
    Sothea, Kim
    Vassilakos, Pierre
    Poda, Armel
    Poda, Evelyn Kasile
    Jaquet, Antoine
    Some, Adolphe
    Petignat, Patrick
    Clifford, Gary
    Horo, Apollinaire
    INTERNATIONAL JOURNAL OF CANCER, 2025, 156 (03) : 598 - 607
  • [42] Ethnic inequalities in mental health and socioeconomic status among older women living with HIV: results from the PRIME Study
    Solomon, Danielle
    Tariq, Shema
    Alldis, Jon
    Burns, Fiona
    Gilson, Richard
    Sabin, Caroline
    Sherr, Lorraine
    Pettit, Fiona
    Dhairyawan, Rageshri
    SEXUALLY TRANSMITTED INFECTIONS, 2022, 98 (02) : 128 - 131
  • [43] Quality of life in an Italian cohort of women living with HIV: preliminary results from IANUA study (Investigation on Antiretroviral Therapy)
    Venturini, Alberto
    Cenderello, Giovanni
    Giannini, Barbara
    Montefiori, Marcello
    Di Biagio, Antonio
    Penco, Giovanni
    Mazzarello, Giovanni
    Orcamo, Patrizia
    Merlano, Caterina
    Setti, Maurizio
    Giacomini, Mauro
    Viscoli, Claudio
    Cassola, Giovanni
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2016, 19
  • [44] Factors associated with mental health outcomes among people living with HIV co-infected with SARS-CoV-2 in France: results from COVIDHIV study
    Yaya, I.
    Yombo-Kokule, L.
    Roucoux, G.
    Thonon, F.
    Zucman, D.
    Duvivier, C.
    Lacombe, K.
    Preau, M.
    Cheret, A.
    Duracinsky, M.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2022, 25 : 251 - 252
  • [45] Changes in body mass index and hemoglobin concentration in breastfeeding women living with HIV with a CD4 count over 350: Results from 4 African countries (The ANRS 12174 trial)
    Some, Eric Nagaonle
    Engebretsen, Ingunn M. S.
    Nagot, Nicolas
    Meda, Nicolas Y.
    Vallo, Roselyne
    Kankasa, Chipepo
    Tumwine, James K.
    Singata, Mandisa
    Hofmeyr, Justus G.
    Van de Perre, Philippe
    Tylleskar, Thorkild
    PLOS ONE, 2017, 12 (05):
  • [46] Positive relations between sexual quality of life and satisfaction with healthcare in women living with HIV and/or HCV: Results from a multicountry study
    Rodriguez, Sara
    Yaya, Issifou
    Huntingdon, Ben
    Juraskova, Ilona
    Preau, Marie
    Etemadi, Fatima
    Dimi, Svetlane
    Carrieri, Maria Patrizia
    Bessonneau, Pascal
    Chassany, Olivier
    Duracinsky, Martin
    PLOS ONE, 2023, 18 (01):
  • [47] Dental implants in individuals living with HIV-1: Results from a prospective study in patients undergoing highly active antiretroviral therapy
    Vidal, Fabio
    Peres, Rafael Vidal
    de Souza, Rodrigo Carvalho
    Goncalves, Cristiane
    Pavan, Priscila
    Goncalves, Lucio Souza
    SPECIAL CARE IN DENTISTRY, 2022, 42 (02) : 112 - 119
  • [48] Depot Medroxyprogesterone Acetate in Combination with a Twice-Daily Lopinavir-Ritonavir-Based Regimen in HIV-Infected Women Showed Effective Contraception and a Lack of Clinically Significant Interactions, with Good Safety and Tolerability: Results of the ACTG 5283 Study
    Luque, Amneris E.
    Cohn, Susan E.
    Park, Jeong-Gun
    Cramer, Yoninah
    Weinberg, Adriana
    Livingston, Elizabeth
    Klingman, Karin L.
    Aweeka, Francesca
    Watts, D. Heather
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (04) : 2094 - 2101
  • [49] HIV and induced abortion among migrants from sub-Saharan Africa living in Ile-de-France: Results of the PARCOURS study
    Pilecco, Flavia B.
    Ravalihasy, Andrainolo
    Guillaume, Agnes
    du Lou, Annabel Desgrees
    JOURNAL OF MIGRATION AND HEALTH, 2024, 10
  • [50] Access to and quality of care for sexual and gender minority women living with HIV in Metro Vancouver, Canada: Results from a longitudinal cohort study
    Perrin, H.
    Shannon, K.
    Lowik, A. J.
    Rich, A.
    Baral, S.
    Braschel, M.
    Deering, K.
    WOMENS HEALTH, 2023, 19